SEC Form D private-offering filing

KIORA PHARMACEUTICALS INC

Name: KIORA PHARMACEUTICALS INC - new SEC Form D private-offering filing, Encinitas, CA
Published: 2026-04-21

A new SEC Form D private-offering notice from Encinitas, CA, a $5,000,000 filer-stated offering target in Biotech. The source filing is one click away.

KIORA PHARMACEUTICALS INC site↗ Verified via SEC Form D

Clinical-stage biopharmaceutical company developing therapies for retinal diseases, including vision-restoring and anti-inflammatory treatments for conditions like retinitis pigmentosa and uveitis.

Filed 2026-04-21Filed to raise $5,000,000First money in 2026-04-06Raised so far $5,000,000HQ (as filed) Encinitas, CASector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Website verified kiorapharma.com↗Named in the filing 8 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.